Industry Updates
This broad category includes articles concerning health insurance costs, carrier and health plan news, changing benefits technology, and surveys by the Kaiser Family Foundation and others on employee benefits.
Dozens of state attorneys general, including California, are calling for Congress to end a practice they say has “exacerbated the problem of manipulated prices and unavailability of certain prescription medications.” The 39 attorneys generals, which includes those representing United States territories and the District of Columbia, urge Congress to pass an act prohibiting pharmacy benefit ...
The executive order was praised by an unlikely source – Mark Cuban, who started Cost Plus Drugs in 2022 in an attempt to control prices through direct-to-consumer transparency.
A new experimental GLP-1 drug, in pill form, could transform the weight loss drug boom. Eli Lilly’s new experimental pill called orforglipron, helped patients shed weight and control blood sugar as well as blockbuster drug Ozempic in a trial of diabetes patients, and the company said it expects to seek regulatory approvals by the end ...
Department of Health and Human Services (HHS) reorganization plans appear to have been revealed through a leaked Office of Management and Budget (OMB) document.
The wide-ranging order requires the Department of Health and Human Services to seek public comment on the drug price negotiation program, which effectively requires manufacturers to agree to lower prices for certain drugs, for potential changes in upcoming years.
Starting in 5 days, the Department of Health and Human Services (HHS) may begin slashing regulations it considers to be unlawful or to exceed the agency’s authority, according to a memorandum sent by the president on Wednesday.
An investigation into the national security implications of pharma imports has been underway for two weeks, the Trump administration disclosed Monday.
California is projected to experience the largest potential losses in Medicaid coverage if federal work requirements are enacted.
Shares of U.S. health insurers jumped on Tuesday after a bigger-than-expected increase in the government’s reimbursement rates for Medicare Advantage plans in 2026 signaled some relief for a sector burdened with steep medical costs. Medicare-focused insurer Humana (HUM.N), opens new tab led gains with a 16% jump, while other health insurers including UnitedHealth Group (UNH.N), opens new tab, ...
President Donald Trump said Tuesday that pharmaceutical imports will soon be hit with “major” tariffs as part of his efforts to drive manufacturing back to the U.S. Drug imports evaded the first round of tariffs that Trump imposed on countries around the world, but the president said they will not be spared. “We’re going to ...